0001778111-22-000008.txt : 20220308
0001778111-22-000008.hdr.sgml : 20220308
20220308164221
ACCESSION NUMBER: 0001778111-22-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220305
FILED AS OF DATE: 20220308
DATE AS OF CHANGE: 20220308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark Bill
CENTRAL INDEX KEY: 0001778111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38257
FILM NUMBER: 22722296
MAIL ADDRESS:
STREET 1: C/O NATIONAL VISION HOLDINGS, INC.
STREET 2: 2435 COMMERCE AVENUE, BUILDING 2200
CITY: DULUTH
STATE: GA
ZIP: 30096
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: National Vision Holdings, Inc.
CENTRAL INDEX KEY: 0001710155
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 464841717
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2435 COMMERCE AVENUE
STREET 2: BLDG. 2200
CITY: DULUTH
STATE: GA
ZIP: 30096-4980
BUSINESS PHONE: (770) 822-3600
MAIL ADDRESS:
STREET 1: 2435 COMMERCE AVENUE
STREET 2: BLDG. 2200
CITY: DULUTH
STATE: GA
ZIP: 30096-4980
4
1
wf-form4_164677571662123.xml
FORM 4
X0306
4
2022-03-05
0
0001710155
National Vision Holdings, Inc.
EYE
0001778111
Clark Bill
C/O NATIONAL VISION HOLDINGS, INC.
2435 COMMERCE AVENUE, BLDG. 2200
DULUTH
GA
30096-4980
0
1
0
0
SVP, Chief People Officer
Common Stock
2022-03-05
4
M
0
639
0
A
14886
D
Common Stock
2022-03-05
4
F
0
193
D
14693
D
Restricted Stock Units
2022-03-05
4
M
0
639
0
D
Common Stock
639.0
13767
D
Each restricted stock unit represents a contingent right to receive one share of NVHI common stock.
On March 5, 2022, 639 restricted stock units vested and 193 shares of the Company's common stock were withheld to satisfy tax withholding obligations. The closing price on March 4, 2022 (as March 5, 2022 fell on a weekend) of the Company's common stock on NASDAQ was $38.55 per share.
On March 5, 2021, the reporting person was granted 1,917 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Jared Brandman, as Attorney-in-Fact
2022-03-08